Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Oral Oncology|March 30, 2017
Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatmentYuehan Zhang, Tim Waterboer, Robert I Haddad, et al.
Frontiers in Oncology|December 13, 2021
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck CancerAdam Luginbuhl, Alyssa Calder, David Kutler, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2018
Using Big Data Analytics to Advance Precision Radiation OncologyTodd R McNutt, Stanley H Benedict, Daniel A Low, et al.
Oral Oncology|February 12, 2016
Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumorsPeter H Ahn, Harry Quon, Bert W O'Malley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303Ann Marie Egloff, Ju-Whei Lee, Corey J Langer, et al.
Advances in Radiation Oncology|September 11, 2018
Evaluation of classification and regression tree (CART) model in weight loss prediction following head and neck cancer radiation therapyZhi Cheng, Minoru Nakatsugawa, Chen Hu, et al.
Practical Radiation Oncology|April 22, 2017
Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice GuidelineDavid J Sher, David J Adelstein, Gopal K Bajaj, et al.
Head & Neck|June 10, 2014
Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial designCristina P Rodriguez, David J Adelstein, Lisa A Rybicki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2017
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer CellsHiroyuki Ozawa, Ruchira S Ranaweera, Evgeny Izumchenko, et al.
Oral Oncology|August 18, 2018
Prospective evaluation of patient reported swallow function with the Functional Assessment of Cancer Therapy (FACT), MD Anderson Dysphagia Inventory (MDADI) and the Sydney Swallow Questionnaire (SSQ) in head and neck cancer patientsLuke C Peng, Xuan Hui, Zhi Cheng, et al.
Pageof 21